CVE-2026-93965aiyiyi121 SxDevOps MCP STDIO Server Management services.py subprocess.Popen command injection
Updated under an hour ago ()
Does this affect you?
It affects aiyiyi121 SxDevOps. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A flaw has been found in aiyiyi121 SxDevOps 1.0/1.1. Affected is the function subprocess.Popen of the file backend/aiops/services.py of the component MCP STDIO Server Management. This manipulation of the argument endpoint_or_command causes command injection. The attack may be initiated remotely. Patch name: 2b4bf8585c3e731e7a8af30801ea46680bc783f9. To fix this issue, it is recommended to deploy a patch. The vendor was contacted early, responded in a very professional manner and quickly released a fixed version of the affected product.
- CVSS
- 6.6 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:L/I:L/A:L/E:X/RL:O/RC:C
- Weakness (CWE)
- CWE-77, CWE-74
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Sep 21, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
aiyiyi121 SxDevOps aiyiyi121:sxdevops | 1.0; 1.1 | CNA record |
References
- https://vuldb.com/vuln/407924vdb-entry, technical-description
- https://vuldb.com/vuln/407924/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-93965third-party-advisory
- https://vuldb.com/submit/944376third-party-advisory
- https://github.com/aiyiyi121/sxdevops/issues/16issue-tracking
- https://github.com/aiyiyi121/sxdevops/commit/2b4bf8585c3e731e7a8af30801ea46680bc783f9patch
- https://github.com/aiyiyi121/sxdevops/product
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.